The Beyfortus shot is expected to be available by this fall and has been shown to reduce the risk of hospitalizations for RSV by 80 percent. Here's what you need to know.
“Making this immunization available means that babies will be able to receive antibodies to prevent severe RSV disease, providing a critical tool to protect against a virus that is the leading cause of hospitalization among infants in the U.S.” Only one shot is needed and can be given to children prior to or during RSV season.for children under 2 years old. Agency advisers considering the antibody shot for infants cast a unanimous vote in June in favor of approving the treatment for infants.
The FDA and Agency advisors reviewed the results from three different clinical trials in which more than 3,200 infants were given the shot. No major safety concerns were seen. No serious adverse reactions were reported, and no safety concerns have been documented. Side effects, including pain at the injection site, rash and fever were uncommon and similar to what babies that were given a placebo experienced.
Unlike Beyfortus, Pfizer’s vaccine would be given to expectant mothers before their newborn’s arrival. In conjunction with this form of injection, a small increase in preterm births has been reported. Officials at the FDA reported that the difference was not statistically significant—meaning that the difference was not large enough to be attributed to the vaccine and could instead have been due to chance or other factors during the mother’s pregnancy.
The CDC recommends that parents talk to their pediatricians about the new vaccine and the importance of preventing severe RSV. You can learn more about
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Babies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, health advisers recommended Thursday.
Consulte Mais informação »
Babies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, heath advisers recommended Thursday.
Consulte Mais informação »
CDC advisers vote to recommend new preventive RSV shot for all infants | CNNAll infants under 8 months of age should get a new antibody shot to protect against hospitalization with respiratory syncytial virus, or RSV, according to a panel of independent experts that advises the United States Centers for Disease Control and Prevention on its immunization recommendations.
Consulte Mais informação »
Babies born in fall and winter should get RSV shots, CDC panel recommendsMany babies should get a shot soon after birth to protect them from RSV, or respiratory syncytial virus, a panel of the Centers for Disease Control and Prevention's outside advisers voted Thursday.
Consulte Mais informação »
Babies Should Get New Drug That Prevents RSV, CDC Panel SaysAn infection with RSV is a cold-like nuisance for most healthy people, but it can be life-threatening for the very young and the elderly. There are no vaccines for babies, so the new drug is expected to fill a critical need.
Consulte Mais informação »